Dexlansoprazole
Top View
- Dexilant (Dexlansoprazole) Delayed Release Capsules in the Treatment of Gastroesophageal Reflux Disease (GERD)
- Ulcer-Heartburn Therapy: Dexilant (Dexlansoprazole), Nexium (Esomeprazole),Tecta (Pantoprazole Magnesium)- Prior Authorization F
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Phase 4 Study in Patients from Asia with Gastroesophageal Reflux Disease Treated with Dexlansoprazole
- DEXILANT (Dexlansoprazole) Label
- Proton Pump Inhibitors
- Proton Pump Inhibitors Review 09/04/2009
- (CD-P-PH/PHO) Report Classification/Justifica
- Proton Pump Inhibitors: Use in Adults
- Occupational Contact Allergy to Proton Pump Inhibitors and Ranitidine
- Nexium® (Esomeprazole) — First-Time Generic
- Dexlansoprazole (Dexilant) Reference Number: HIM.PA.05 Effective Date: 01.01.20 Last Review Date: 02.20 Revision Log Line of Business: HIM
- Malaysian Statistics on Medicines 2015-2016
- Laryngopharyngeal Reflux Disease
- Managing Gastroesophageal Reflux Disease with Dexlansoprazole MR Open Access to Scientific and Medical Research DOI
- Effect of a Preoperative Proton Pump Inhibitor and Gastroesophageal
- List of Selected Drugs
- Proton Pump Inhibitors Associated Acute Kidney Injury And